抗癌化疗的进展:拓扑异构酶、热休克蛋白90、mTOR和酪氨酸激酶抑制剂

{"title":"抗癌化疗的进展:拓扑异构酶、热休克蛋白90、mTOR和酪氨酸激酶抑制剂","authors":"K. Choi, S. Lee, Miji Kwon, Seyoung Hong, Hee Ho Park, Kwang Suk Lim","doi":"10.7841/ksbbj.2021.36.2.99","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17865,"journal":{"name":"KSBB Journal","volume":"25 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development of Anticancer Chemotherapy: Inhibitors of Topoisomerase, HSP90, mTOR and Tyrosine Kinase\",\"authors\":\"K. Choi, S. Lee, Miji Kwon, Seyoung Hong, Hee Ho Park, Kwang Suk Lim\",\"doi\":\"10.7841/ksbbj.2021.36.2.99\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17865,\"journal\":{\"name\":\"KSBB Journal\",\"volume\":\"25 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"KSBB Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7841/ksbbj.2021.36.2.99\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"KSBB Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7841/ksbbj.2021.36.2.99","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}